Security Snapshot

ISHARES TR - U.S. MED DVC ETF (IHI) Institutional Ownership

CUSIP: 464288810

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

507

Shares (Excl. Options)

30.93MFull value: 30,925,375 · shares · 30 Jun 2026

Price

$49.41

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+3,459,877
Value change
+$168,960,776
Number of holders
507
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$52.69
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IHI - ISHARES TR - U.S. MED DVC ETF is tracked under CUSIP 464288810.
  • 507 institutions reported positions in Q2 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 511 to 507 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $1.48BFull value: $1,477,903,686 · USD · 31 Mar 2026
    to
    $1.53BFull value: $1,530,021,866 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 507 institutions filings for Q2 2026.

Open SEC evidence

Security key

464288810

13F reference period

Q2 2026

13F holders

507

13D/G owners

0

CIK / CUSIP context first

As of 30 Jun 2026, 507 institutional investors reported holding
30.93MFull value: 30,925,375 · shares · 30 Jun 2026
shares of ISHARES TR - U.S. MED DVC ETF (IHI).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 2,874,978 $134,515,307 -$49,233,028 $51.15 171
2026 Q2 30,925,375 $1,530,021,866 +$168,960,776 $49.41 507
2026 Q1 27,675,154 $1,477,903,686 +$5,801,273 $53.35 511
2025 Q4 27,452,655 $1,706,800,719 -$94,060,072 $62.15 551
2025 Q3 28,066,095 $1,686,567,273 -$139,681,287 $60.08 519
2025 Q2 30,890,113 $1,934,078,245 -$71,129,888 $62.64 541
2025 Q1 32,041,775 $1,926,739,389 +$243,060,259 $60.19 549
2024 Q4 28,259,914 $1,650,015,884 -$370,655,958 $58.35 559
2024 Q3 34,262,358 $2,029,447,469 -$225,531,189 $59.22 550
2024 Q2 38,245,282 $2,143,068,382 -$86,251,564 $56.04 541
2024 Q1 39,518,066 $2,313,517,861 +$2,461,048 $58.59 576
2023 Q4 40,428,388 $2,182,412,405 -$55,966,831 $53.97 572
2023 Q3 41,264,588 $2,005,645,231 +$109,175,798 $48.50 539
2023 Q2 38,686,875 $2,181,537,226 -$172,775,979 $56.46 580
2023 Q1 41,867,910 $2,260,877,671 -$12,203,369 $53.98 550
2022 Q4 42,031,865 $2,211,056,470 -$45,315,080 $52.57 567
2022 Q3 43,464,582 $2,055,482,136 -$234,169,711 $47.18 542
2022 Q2 48,569,498 $2,448,683,360 +$15,986,913 $50.44 579
2022 Q1 47,889,171 $2,918,872,393 -$350,481,234 $60.96 622
2021 Q4 53,812,177 $3,539,114,281 +$81,661,366 $65.85 653
2021 Q3 49,806,746 $3,128,547,092 +$2,508,306,462 $62.78 564
2021 Q2 7,826,817 $2,826,778,825 -$1,137,455,368 $361.04 536
2021 Q1 11,686,783 $3,876,852,987 -$1,081,044,875 $330.36 561
2020 Q4 14,983,493 $4,910,407,530 +$110,672,621 $327.30 575
2020 Q3 14,494,165 $4,339,229,620 +$456,702,348 $299.62 482
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .